Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.83 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.83 |
| ▸ | ATM | Q13315 | 1/20 | 0.83 |
| ▸ | CA9 | Q16790 | 1/20 | 0.83 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.78 |
| ▸ | LMNA | P02545 | 4/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.77 |
| ▸ | HTT | P42858 | 1/20 | 0.77 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.74 |
| ▸ | CNR2 | P34972 | 1/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17827613 | 0.93 | CA12 (0.73) | CA12CYP1A2CYP3A4ATMCA9 | |
| SCHEMBL28113725 | 0.91 | CA12 (0.73) | CA12CYP1A2CYP3A4ATMCA9 | |
| SCHEMBL26154030 | 0.91 | CA12 (0.71) | CA12CYP1A2CYP3A4ATMCA9 | |
| SCHEMBL5960116 | 0.91 | MEN1 (0.73) | CA12CYP1A2CYP3A4ATMCA9 | |
| SCHEMBL5960052 | 0.91 | CA12 (0.71) | CA12CYP1A2CYP3A4ATMCA9 | |
| SCHEMBL3925035 | 0.91 | CA12 (0.71) | CA12CYP1A2CYP3A4ATMCA9 | |
| SCHEMBL27950177 | 0.91 | CA12 (0.71) | CA12CYP1A2CYP3A4ATMCA9 | |
| SCHEMBL27950175 | 0.91 | CA9 (0.71) | CA12CYP1A2CYP3A4ATMCA9 | |
| SCHEMBL4662819 | 0.91 | CA12 (0.87) | CA12CYP1A2CYP3A4ATMCA9 | |
| SCHEMBL198318 | 0.91 | CA12 (1.00) | CA12CYP1A2CYP3A4ATMCA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250109098-A1 | METHOD FOR PREPARING BENZYLAMINE DERIVATIVE THROUGH AMINATION OF BENZYLIC C-H BOND UNDER VISIBLE LIGHT-INDUCED NICKEL CATALYSIS | SHANGHAI OURCHEM BIO-TECHNOLOGY CO., LTD. (CN) | 2025-04-03 | — | — | US | disclosed |
| WO-2024164666-A1 | METHOD FOR PREPARING BENZYLAMINE DERIVATIVE BY VISIBLE LIGHT-PROMOTED NICKEL-CATALYZED AMINATION OF BENZYL C-H BONDS | 上海沃凯生物技术有限公司 | 2024-08-15 | — | — | WO | disclosed |
| CN-116063209-B | Method for preparing benzylamine derivative by catalyzing amination of benzyl C-H bond through nickel under promotion of visible light | 上海沃凯生物技术有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-20230157996-A1 | SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD AND USE THEREOF | Shenzhen Bay Laboratory (CN) | 2023-05-25 | — | — | US | disclosed |
| US-20230159469-A1 | NOVEL PHTHALAZINE DERIVATIVE HAVING ECTONUCLOEOTIDE PYROPHOSPHATASE/PHOSPHODIESTE RASE INHIBITORY ACTIVITY, AND USE THEREOF | TXINNO BIOSCIENCE INC. (KR) | 2023-05-25 | — | — | US | disclosed |
| CN-116063209-A | Method for preparing benzylamine derivative by catalyzing amination of benzyl C-H bond through nickel under promotion of visible light | 上海沃凯生物技术有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-112047865-B | Method for synthesizing N-alkyl sulfonamide in water | 南京理工大学 | 2022-12-02 | — | — | CN | disclosed |
| CN-112047865-A | Method for synthesizing N-alkyl sulfonamide in water | 南京理工大学 | 2020-12-08 | — | — | CN | disclosed |
| CN-104418678-B | A kind of method of synthetic N-alkyl sulfonamide derivatives | NANJING UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2016-05-18 | — | — | CN | disclosed |
| CN-104418678-A | Method for synthesizing N-alkyl sulfonamide derivative | UNIV NANJING SCIENCE & TECH | 2015-03-18 | — | — | CN | disclosed |
| CN-103553978-A | Sulfamide benzylation method | UNIV CHONGQING | 2014-02-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157996-A1 | SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD AND USE THEREOF | SSB, EBNA1BP2, PML | CA12 3663/4885CYP1A2 4750/4885CYP3A4 4532/4885 |
| US-20250109098-A1 | METHOD FOR PREPARING BENZYLAMINE DERIVATIVE THROUGH AMINATION OF BENZYLIC C-H BOND UNDER VISIBLE LIGHT-INDUCED NICKEL CATALYSIS | HRH3, HRH4, HRH2 | CA12 2011/4885CYP1A2 1806/4885CYP3A4 1539/4885 |
| US-20230159469-A1 | NOVEL PHTHALAZINE DERIVATIVE HAVING ECTONUCLOEOTIDE PYROPHOSPHATASE/PHOSPHODIESTE RASE INHIBITORY ACTIVITY, AND USE THEREOF | ENPP1, ENPP3, PPA1 | CA12 3292/4885CYP1A2 4589/4885CYP3A4 4632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.